Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a gateway to the proteome. The Company’s initial product, the Proteograph Product Suite (Proteograph), is an integrated solution that includes engineered nanoparticles, consumables, automation instrumentation and software to perform proteomic analysis at scale in a matter of hours. Proteograph leverages its engineered nanoparticle (NP) technology to provide large-scale access to the proteome. Its engineered NPs provide unbiased sampling of intact proteins across the dynamic range of the proteome, capturing molecular information at the peptide level, including protein variants. It is focused on adoption of the Proteograph with customers in the proteomics and genomics markets. The Company is initially focused on research applications for the Proteograph product suite and is selling and marketing the Proteograph for research use only (RUO).
|
|
|
|
|
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
Options are not suitable for all investors as the special risks inherent to options trading may
expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
Copyright © 2023. All rights reserved.